The FDA advisory panel's recommendation is a win for Covid vaccine makers Pfizer, Moderna and Novavax, which will race to deliver updated shots for the fall.
Europe s medicine regulators on
Tuesday backed the World Health Organization s recommendation to
update the antigen composition of COVID-19 vaccines to target
one of the currently dominant XBB. | June 6, 2023
Novavax s head of research and development said an updated vaccine the company is already producing is likely to be protective against other fast-growing coronavirus variants circulating in the US.
(Removes extraneous word in paragraph 9) By Michael Erman (Reuters) - Novavax Inc's head of research and development on Monday said an updated COVID-1.